Patrick Haley
Corporate Officer/Principal en EXELIXIS, INC. .
Fortuna: 10 M $ al 31/03/2024
Perfil
Patrick J.
Haley's current job is as the Executive Vice President-Commercial at Exelixis, Inc. His former job was as the Group Manager-Product at Genentech, Inc. from 2007 to 2010.
Mr. Haley completed his undergraduate degree at Duke University and holds an MBA from the Stephen M.
Ross School of Business.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
EXELIXIS, INC.
0.14% | 23/02/2024 | 419 053 ( 0.14% ) | 10 M $ | 31/03/2024 |
Cargos activos de Patrick Haley
Empresas | Cargo | Inicio |
---|---|---|
EXELIXIS, INC. | Corporate Officer/Principal | 01/11/2014 |
Antiguos cargos conocidos de Patrick Haley.
Empresas | Cargo | Fin |
---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/01/2010 |
Formación de Patrick Haley.
Duke University | Undergraduate Degree |
Stephen M. Ross School of Business | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
EXELIXIS, INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Patrick Haley